FDA recall D-0143-2023

Product

Lidocaine Hydrochloride Jelly USP, 2%, Packaged as (a) 5 mL tube (NDC 17478-711-10) x10 per box NDC 17478-711-31; (b) 30 mL tube NDC 17478-711-30; Rx only, Manufactured by: Akorn, Inc., Lake Forest, Il 60045.

Reason for recall

CGMP Deviations:

Distribution

Nationwide in the USA

Key facts

Status

Ongoing

Initiation date

2022-10-13

Report date

2023-01-25

Voluntary/Mandated

Voluntary: Firm initiated

Location

Gurnee, IL, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0143-2023